Metal complexes

1. A compound of formula (1)

M(L) n (L′) m   formula (1)

wherein said compound contains a moiety M(L) n of formula (2)

wherein M is bonded to a bidentate ligand L via X and a carbon atom C, and

wherein:

M is a metal selected from the group consisting of iridium, rhodium, platinum, and palladium;

X is, identically or differently on each occurrence, CR 1 or N;

Y is, identically or differently on each occurrence, a single bond; a divalent group selected from the group consisting of C(R 1 ) 2 , C(═O), O, S, SO, SO 2 , NR 1 , PR 1 , and P(═O)R 1 ; or an aliphatic, aromatic, or heteroaromatic hydrocarbon having 5 to 60 atoms, which in each case is optionally substituted by one or more radicals R 3 ;

R 1 is, identically or differently on each occurrence, H, D, F, Cl, Br, I, N(R 2 ) 2 , CN, NO 2 , Si(R 2 ) 3 , B(OR 2 ) 2 , C(═O)R 2 , P(═O)(R 2 ) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms, a straight-chain alkenyl or alkynyl group having 2 to 40 C atoms, or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy, or thioalkoxy group having 3 to 40 C atoms, each of which is optionally substituted by one or more radicals R 2 , and wherein one or more non-adjacent CH 2 groups is optionally replaced by R 2 C═CR 2 , C≡C, Si(R 2 ) 2 , Ge(R 2 ) 2 , Sn(R 2 ) 2 , C═O, C═S, C═Se, C═NR 2 , P(═O)(R 2 ), SO, SO 2 , NR 2 , O, S, or CONR 2 , and wherein one or more H atoms are optionally replaced by D, F, Cl, Br, I, CN, NO 2 , an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, optionally substituted by one or more radicals R 2 , an aryloxy or heteroaryloxy group having 5 to 60 aromatic ring atoms, optionally substituted by one or more radicals R 2 , a diarylamino group, diheteroarylamino group, or arylheteroarylamino group, having 10 to 40 aromatic ring atoms, optionally substituted by one or more radicals R 2 , or a combination of two or more of these groups; and wherein two or more radicals R 1 optionally define a mono- or polycyclic, aliphatic, aromatic and/or benzo-fused ring system;

R 2 is, identically or differently on each occurrence, H, D, F, Cl, Br, I, N(R 3 ) 2 , CN, NO 2 , Si(R 3 ) 3 , B(OR 3 ) 2 , C(═O)R 3 , P(═O)(R 3 ) 2 , S(═O)R 3 , S(═O) 2 R 3 , OSO 2 R 3 , a straight-chain alkyl, alkoxy, or thioalkoxy group having 1 to 40 C atoms, a straight-chain alkenyl, or alkynyl group having 2 to 40 C atoms, or a branched or cyclic alkyl, alkenyl, alkynyl, alkoxy, or thioalkoxy group having 3 to 40 C atoms, each of which is optionally substituted by one or more radicals R 3 , wherein one or more non-adjacent CH 2 groups are optionally replaced by R 3 C═CR 3 , C≡C, Si(R 3 ) 2 , Ge(R 3 ) 2 , Sn(R 3 ) 2 , C═O, C═S, C═Se, C═NR 3 , P(═O)(R 3 ), SO, SO 2 , NR 3 , O, S, or CONR 3 , and wherein one or more H atoms are optionally replaced by D, F, Cl, Br, I, CN, NO 2 , an aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, optionally substituted by one or more radicals R 3 , an aryloxy or heteroaryloxy group having 5 to 60 aromatic ring atoms, optionally substituted by one or more radicals R 3 , a diarylamino group, diheteroarylamino group, or arylheteroarylamino group having 10 to 40 aromatic ring atoms, optionally substituted by one or more radicals R 3 , or a combination of two or more of these groups; and wherein two or more adjacent radicals R 2 optionally define a mono- or polycyclic, aliphatic, or aromatic ring system;

R 3 is, identically or differently on each occurrence, H, D, F, or an aliphatic, aromatic and/or heteroaromatic hydrocarbon radical having 1 to 20 C atoms, wherein one or more H atoms are optionally replaced by F; and wherein two or more substituents R 3 optionally define a mono- or polycyclic, aliphatic, or aromatic ring system;

L′ is, identically or differently on each occurrence, any co-ligand;

W is a moiety of formula (3)

 wherein the ring A is optionally any substituted or unsubstituted aliphatic, aromatic or heteroaromatic ring having 5 to 60 atoms, or a substituted or unsubstituted polycyclic ring system, optionally condensed with the adjacent rings;

U are, identically or differently on each occurrence, selected from the group consisting of —C(R 1 ) 2 , —Si(R 1 ) 2 , N, —NR 1 , —O, —S, —C(═O), —S(═O), —SO 2 , —CF 2 , —SF 4 , —P, —P(═O)R 1 , —PF 2 , —P(═S)R 1 , —As, —As(═O), —As(═S), —Sb, —Sb(═O), and —Sb(═S);

q, r are, independently of one another, 0 or 1;

p is greater than or equal to 1;

t is 0, 1, or 2;

n is 1, 2, or 3 if M is iridium or rhodium and 1 or 2 if M is platinum or palladium;

m is 0, 1, 2, 3, or 4;

wherein n and m are selected so that the coordination number on the metal is 6 if M is iridium or rhodium and 4 if M is platinum or palladium;

and wherein a plurality of ligands L are optionally linked to one another, or L is optionally linked to L′ via any bridge Z, defining a tridentate, tetradentate, pentadentate or hexadentate ligand system.

2. The compound of claim 1 , wherein the moiety M(L) n is a compound of formulae (4) to (20):

wherein:

Q is, identically or differently on each occurrence, R 1 C═CR 1 , R 1 C═N, O, S, Se, or NR 1 ;

V is, identically or differently on each occurrence, O, S, Se, NR 1 , or C(R 1 ) 2 .

3. The compound of claim 1 , wherein the moiety M(L) n is a compound of formula (4), (9), (12), or (18):

4. The compound of claim 1 , wherein the moiety M(L) n is a compound of formula (4) or (12):

5. The compound of claim 1 , wherein X is CR 1 for all atoms which are not bonded directly to M.

6. The compound of claim 1 , wherein the moiety M(L) n is a compound of formulae (25) to (28):

7. The compound of claim 1 , wherein ring A of formula (3) is a compound of formula (3a):

wherein T is selected from the group consisting of —C(R 1 ) 2 , —N, —NR 1 , —O, and —S.

8. The compound of claim 1 , wherein W is a compound of formulae (66) to (71) and (78) to (89):

wherein the dotted line represents the bond between W and Y of formula (2).

9. The compound of claim 1 , wherein Y is, identically or differently on each occurrence, a single bond or an aliphatic, aromatic or heteroaromatic hydrocarbon having 5 to 60 atoms, which in each case is optionally substituted by one or more radicals R 3 .

10. The compound of claim 1 , wherein Y is a compound of formulae (33) to (63):

wherein X′ is selected from the group consisting of O, S, Se, NR 1 , C(R 1 ) 2 , and S(═O) 2 , and the dotted lines represent the bond to W or to the part of the organic ligand which is bonded directly to the metal M.

11. A process for preparing the compound of claim 1 , wherein said process comprises reacting the corresponding free ligands with metal alkoxides of formula (155), with metal ketoketonates of formula (156), or with metal halides of formula (157):

wherein Hal is F, Cl, Br, or I.

12. A formulation comprising at least one compound of claim 1 and at least one solvent.

13. An electronic device comprising at least one compound of claim 1 .

14. The electronic device of claim 1 , wherein said electronic device is an organic electroluminescent device, organic integrated circuit, organic field-effect transistor, organic thin-film transistor, organic light-emitting transistor, organic solar cell, organic optical detector, organic photoreceptor, organic field-quench device, light-emitting electrochemical cell, or organic laser diode.

15. The organic electroluminescent device of claim 13 , wherein the compound of claim 17 is employed as emitting compound in one or more emitting layers.

16. The organic electroluminescent device of claim 15 , wherein the compound of claim 17 is employed in combination with a matrix material.

17. The organic electroluminescent device of claim 16 , wherein the matrix material is selected from the group consisting of ketones, phosphine oxides, sulfoxides, sulfones, triarylamines, carbazole derivatives, indolocarbazole derivatives, indenocarbazole derivatives, azacarbazole derivatives, bipolar matrix materials, silanes, azaboroles, boronic esters, triazine derivatives, zinc complexes, diaza- or tetraazasilole derivatives or diazaphosphole derivatives, and mixtures of these matrix materials.

18. A process for the therapy, prophylaxis and/or diagnosis of diseases and/or cosmetic conditions comprising utilizing the compound of claim 1 .

19. A process for the therapy, prophylaxis and/or diagnosis of diseases and/or cosmetic conditions comprising utilizing the electronic device of claim 13 .